Low molecular weight heparin stimulates megakaryocytopoiesis in bone-marrow transplantation patients

Reuven Or, Sharon Elad, Ofer Shpilberg, Amiram Eldor

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

The use of low molecular weight heparin (LMWH) as prophylaxis for veno-occlusive disease of the liver has been studied in patients undergoing bone marrow transplantation (BMT). The present study analyzes the effect of LMWH on the time course of platelet recovery after BMT. Significantly accelerated platelet recovery in conjunction with lessened requirements of platelet transfusions was observed in the LMWH-treated patients.

Original languageEnglish
Pages (from-to)46-48
Number of pages3
JournalAmerican Journal of Hematology
Volume53
Issue number1
DOIs
StatePublished - 22 Oct 1996
Externally publishedYes

Keywords

  • bone-marrow transplantation
  • low molecular weight heparin
  • megakaryocytopoiesis

Fingerprint

Dive into the research topics of 'Low molecular weight heparin stimulates megakaryocytopoiesis in bone-marrow transplantation patients'. Together they form a unique fingerprint.

Cite this